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ABSTRACT 
Objective: Endocrine regulation strategies are widely used for synchronization of fertility, but in some cichlids species, the treatments are not 
always effective. This study used tilapia (Oreochromis niloticus) as a model cichlid fish to evaluate homologous pituitary extract in-vitro and in-vivo 
bioassays.  
Methods: In this study, guinea pig Leydig cells, tilapia follicular cells, and female tilapia were treated with tilapia pituitary extract (TP) to evaluate 
the ability of TP to modulate steroid production in-vitro and in-vivo. Sex steroid hormone quantification was performed using enzyme immunoassay 
(ELISA), and the relative vitellogenin (Vtg) level was measured using Western blot during the maturation cycle of female fish. 
Results: Treatment with TP in-vitro significantly increased testosterone and estradiol (E2) levels in guinea pig Leydig cells and in tilapia follicular 
cells, respectively. In-vivo experiments showed a significant increase in plasma E2 and Vtg concentration in the TP-treated female. Interestingly, 
40% oocyte maturation was observed in TP-treated adult female tilapia whereas, only 7% was observed in the control group. TP treatment is 
increased relative fecundity significantly, reaching a production of 15.7±5.8 oocytes/g of female.  
Conclusion: The outcome of this study suggests that TP has a potential use in the control of cichlid fish reproduction and can be used as an 
alternative method for fish fry production. 
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INTRODUCTION 
The supply of quality fish seed is a key factor in the expansion of fish 
farming. Currently, fish seed demand is very high and increasing, but 
supply is not up to the mark. There is always a need to look for 
alternative methods and sources that will help fulfill the fish seed 
requirements of this industry [1, 2]. 
Endocrine regulation strategies are widely used for synchronization 
of fertility and for enhancing fish, but treatment success varies, 
depending on the species. In this sense, carp pituitary extracts and 
gonadotropin-releasing hormone analogs (GnRH) are widely used in 
the critical stage of fish reproduction [2]. However, this treatment is 
not effective in many endemic cichlids species in Ecuador as “vieja 
azul” (Andinoacara rivulatus) and “vieja roja” (Cichlasoma festae). 
Moreover, these methods coupled with photoperiod affect the 
quality of oocytes [1, 3]. 
Reports suggest changes in the structure of glycosidic residues 
present in heterodimers constituting the follicle stimulating 
hormone (FSH), especially in the β-subunit that may alter the 
steroidogenic signal response when bound to its specific membrane 
receptor. This structure in tilapia is specific for the genus 
Oreochromis [4, 5]. Therefore, the use of tilapia pituitary extracts 
(TP) may have a synergistic effect on steroidogenic processes in 
vitro and in vivo bioassays. 
This study used tilapia (Oreochromis niloticus), a highly productive 
performance fish, as a cichlid model, and homologous pituitary 
extract to treat i) cells in-vitro to determine the biological activity of 
TP in a dose-dependent manner, and ii) female tilapia, during their 
reproductive period, to determine the effect of TP on plasma 
estradiol (E2) and vitellogenin (Vtg) levels and their impact on the 
development and size of oocytes. 
MATERIALS AND METHODS 
In-vitro bioassays 
The experiments with Leydig and follicular cell models were 
conducted according to the principles and procedures approved by 
Universidad de Chile. The pituitaries were obtained during the 
spawning period from 200 female tilapias. Fresh pituitaries were 
treated with acetone (96%), lyophilized and divided into aliquots. 
The biological activity of TP was compared to carp pituitary extract 
(CP) (Argent Labs, USA), in a concentration of 2.5 mg/ml of 
physiological solution. 
Testis from guinea pigs (Cavia porcellus) with average weight 
1123±172 g were dissected, washed with distilled water, and 
immersed in HAM medium (Sigma, USA) pH 7.4 to obtain Leydig 
cells. Subsequently, collagenase (0.25 mg/ml) from Clostridium 
histolyticum (Sigma, USA) was added and incubated at 37 °C with 
constant stirring for 15 min, followed by centrifugation at 350 g for 
10 min at 27 °C. The supernatant was removed, and the pellet was 
suspended in 5 ml of HAM medium. The biological activity of TP and 
CP were measured after 12 h by triplicate. As control used Leydig 
cells, treated with physiological solution [6].  
Follicular cells were obtained from ovaries adult females of tilapia 
(weight 80±5 g) and trout (weight 290±17 g). Ovaries were divided 
into uniformly sized fragments (20 mg each) and transferred to a 96-
well culture plate containing HAM balanced salts, penicillin (100 
IU/ml), streptomycin (0.1 mg/ml), nystatin (1.25 IU/ml) and 0.05% 
BSA (Sigma, USA) at pH 7.4 [7]. The gonads were washed three times 
for 1 h intervals and incubated at 26 °C. In the last wash, 0.2 mM 
theophylline was added together with the TP and CP treatments. 
Experiments were carried out in triplicates during 18 h. The 
supernatants were used to measure E2 levels and to build the 
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saturation curve [6-9]. Male, female plasma and young ovarian 
tissue, treated with a physiological solution, were used as a control.  
In-vivo bioassays 
The experimental evaluation was conducted under real production 
conditions in Ecuador. Forty-eight adults tilapia (weight 319.8±38.6 
g) both male and female (1:1) were divided randomised into 8 tanks, 
containing 1500 L water. Ideal rearing conditions, including water 
recirculation system, a temperature of 28±2 °C and natural light 
were maintained. Two different treatments by triplicate were 
established, the TP treatment and the control. Twelve female fish 
were treated with an intraperitoneal injection of pituitary extract 
(5 µg/g body weight). Post treatment, blood samples were drawn 
weekly from fish caudal vessels using a heparinized syringe, and 
plasma samples were isolated by centrifugation at 1500 g for 15 
min and 1 mM of phenylmethylsulfonyl fluoride (PMSF) was 
added. Samples were stored at-80 °C until levels of E2 and Vtg in 
were analyzed. During spawning, ovaries were dissected from fish 
and parameters such as a gonad somatic index (GSI), relative 
fecundity (FR), weight and volume of oocytes were measured 
immediately. 
Analysis of hormonal steroids 
Quantification of testosterone and E2 levels from both in-vitro and 
in-vivo studies were performed by enzyme immunoassay technique 
(ELISA) using commercial kits protocols (Cayman Chemicals 
Company, MI, USA). All samples were analyzed in duplicate, and a 
separate standard curve was run for each ELISA plate. Steroid levels 
in samples were further validated by using different serial dilutions 
and ran in parallel to the relevant standard curve. The detection 
limit was 20 pg/ml. 
Vitellogenin analysis 
Vtg was quantified from stored plasma samples using quaternary 
ammonium anion-exchange columns procured from Sortobind MA 
Q-15 (Sartorius, Germany) [10]. Western blot with polyclonal anti-
Vtg was used to validate the previous essay [11]. This detection was 
used as a reference to locate the protein in SDS-PAGE for subsequent 
densitometry image analysis, to calculate the relative concentration 
with image J free software.  
Statistical analysis 
Data from in-vivo assays for steroids and Vtg levels were monitored 
for homogeneity of variance and normality with the Levene and 
Shapiro-Wilk tests, respectively. An analysis of variance (ANOVA) 
was performed to determine the existence of significant differences 
among treatments. Differences in mean values were determined by 
Tukey´s test. Data from in-vitro assays were analyzed by the Kruskal-
Wallis nonparametric test followed by the Mann-Whitney test. The 
results were considered significant if p≤ 0.05. The data were 
expressed as mean±SEM with Info-stat 5.0 statistical software. 
RESULTS 
In-vitro assays 
The effect of CP on gonadotropins hormones is well documented in 
other fish species [2]. Hence, it is important to note that 12 h after 
treatments, secretion testosterone levels in Leydig cells increased 
from 0.54±0.2 ng/ml to 1.57±0.34 ng/ml in CP treatment (n=9; 
P=0.0001). However, in TP treatment also increased to 1.14±0.12 
ng/ml (fig. 1). The intra assay coefficient of variation (CV), calculated 
by measuring replicates of the same sample within the assay, was 
estimated at 6.2%. The inter assay CV, calculated by measuring 
replicates of the same sample in different assays, was 9.3%. 
Similarly, secretion E2 levels in trout follicular cells increased from 
0.29±0.04 ng/ml to 3.26±0.19 ng/ml and 3.85±0.11 ng/ml with TP 
and CP treatments, respectively (n=21; P<0.0001). In the same 
experiment, E2 levels on tilapia follicular cells increased from 
2.34±0.14 ng/ml to 3.195±0.34 ng/ml and 2.812±0.299 ng/ml with 
TP and CP treatments, respectively (Fig.2). These results may 
indicate that TP and CP have a biological activity in not only in trout 
cells but also in tilapia cells. 
 
Fig. 1: Effect of tilapia and carp pituitary extracts on the levels 
of testosterone in guinea pigs Leydig cells. The results are 
expressed as mean±SEM, n= 9. ***p= 0.0001 
 
 
Fig. 2: Effect of tilapia and carp pituitary extracts on the levels 
of estradiol in tilapia and trout follicular cells. The results are 
expressed as mean±SEM, n=21. ***p = 0.0001; **p = 0.001 
 
Moreover, in challenge tests of TP concentrations between 0.13 to 
7.5 mg/ml. of culture cells, the E2 response with 2.9 to 3.8 ng/ml. on 
average. The E2 response was higher at low concentrations of TP, 
while a high extract concentration showed an equal or lowers effect. 
Significant differences were detected a dose of 0.38 mg/ml 
compared with tilapia male plasma (n=48; P<0.0001; fig. 3). 
 
 
Fig. 3: Effect of tilapia pituitary extracts on the levels of 
estradiol in tilapia follicular cells in different concentrations. 
Controls were performed with ovaries, male and female plasma 
of the same species. The results are expressed as mean±SEM, n= 
48. ***p = 0.0001 
 
In-vivo assays 
The adult fishes showed a positive response to the TP treatment. 
The GSI was 3.5%, and FR showed 15.7 oocytes/g female, with 
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significant differences to the control (n= 24; P<0.005). The oocytes 
diameters and volume showed differences between TP and control 
treatments (fig. 4). 
 
 
Fig. 4: Reproductive parameters of adult O. niloticus females 
after treatment with Tilapia pituitary. The results are 
expressed as mean±SEM, n= 24. **p = 0.001 
 
 
Fig. 5: The proportion of oocytes according to the diameter of 
the major axis (mm) and stage of development.<0.7-0.9 
mm>pre vitellogenic; <1.6-1.9 mm>vitellogenic; >2 mm. mature 




Fig. 6: Plasma estradiol and vitellogenin levels in adult females 
of Oreochromis niloticus under two experimental conditions: 
(A) control and (B) pituitary extract. The results are expressed 
as mean±SEM, n= 24. **p = 0.001; *p = 0.01 
Oocytes volume and its symmetry analysis detected significant 
differences between control and TP treatment (n= 200; P<0.0009). It 
was noted that the treatment with pituitary extract have a higher 
proportion of mature oocytes (>2 mm) and symmetrically better formed 
in the early stages (<1.6-1.9 mm). The proportion of maturity of oocytes 
is more homogeneous in induced TP treatment (fig. 5). 
The plasma E2 levels were between 8.9 and 22.9 ng/ml in the 
control and between 7.74 and 23.14 ng/ml after TP treatment in the 
first five days. In the next 20 d, the E2 levels reached at 18.5 ng/ml 
and 18.2 ng/ml with control and TP treatment, respectively. On the 
other hand, plasma Vtg levels during the reproduction period 
showed significant differences between days (n=24; P=0.0002). This 
variation ranges from 3.9 to 5.09 mg/ml in the control and between 
3.17 and 2.5 mg/ml after TP treatment in the first five days. In the 
next 20 d, the Vtg levels reached at 2.5 mg/ml and 4.8 ng/ml with 
control and TP treatment, respectively. Vtg levels were different 
between treatments (n=24; P<0.05), in which TP generates a gradual 
and proportional increase in the reproduction time (fig. 6). 
DISCUSSION 
The biological activity of the tilapia pituitary extract was quantified 
in different experimental models such as guinea pig’s Leydig cells 
and fish follicular cells. The results show statistical differences with 
CP as a commercial product. This variation could be explained by 
heterodimers' glycosidic structure changes, especially in tilapia FSH 
β altering the translation of the steroidogenic signal, given by the 
interaction with the receptor. The degree of glycosylation of the 
structure is different and represents 30-35% of the molecular mass, 
allowing the functionality of the hormone. The tilapia hormone 
structure is specific for the genera Oreochromis and Tilapia [5, 7]. 
Furthermore, the cell culture tests showed similar time response to 
generate steroid hormone and obtaining positive results at low 
concentrations of the homologous pituitary. Under these 
circumstances, homologous pituitary tilapia extracts may have a 
synergistic effect on steroidogenic processes involving reproductive 
tissues. Nevertheless, taking into consideration that, for in-vivo tests, 
some diseases may occur, and that results may be highly variable 
[2], it is necessary to develop and carry out more accurate in-vitro 
experiments. Pituitary extracts tend to go directly into the 
circulatory system where gonadotropins are released, generating a 
wider range of possible responses based on homology of receptor 
binding sites and the presence of co-activator and co-repressor 
proteins [6, 12]. 
The present study detected differences between TP treatment and 
control in-vivo bioassays. The system improves hormonal processes 
after the tenth day, increasing the production of Vtg levels, ovarian 
growth and reduced concentrations of E2. These findings suggest 
that each cell regulates its own receiver for a given response. Thus, 
when the hormones are released in pulsatile format lower doses, the 
response will be sustained by the receptor, but when the release is 
continuous at higher doses, the target cell will be saturated, and the 
receptors change their signaling and desensitize. Therefore, 
measuring the concentration of circulating hormone is an 
approximation in the phenomenon, in which the number of cellular 
receptors plays a pivotal role [6]. 
FR showed interesting differences between treatments, especially 
with the proportion of mature oocytes obtained in the control group, 
where the normal breeding range with Tilapia go from 1.3 to 7.2 
eggs/g female [13, 14]. However, the results obtained by the provision 
of pituitary extract can generate double the capacity of the control, and 
improve the number of embryos in the production process. 
Oocytes volume and its symmetry analysis detected significant 
differences between control and experimental treatment. It was 
noted that the treatment with pituitary extract has a higher 
proportion of mature oocytes and symmetrically better formed in 
the early stages. The stages of oocyte development have a direct 
relationship with the individual volume of the oocyte. The increase 
in production capacity, in this case, could be due to high availability 
of yolk precursors and environmental factors such as temperature 
and normal photoperiod in the region. Furthermore, reports defined 
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that the growth of the oocyte is directly related to the endocytosis of 
Vtg and other compounds in the retention period of meiosis in 
prophase I, until maximum growth, wherein the meiosis to 
metaphase II restarts [2, 15]. 
In summary, circulating gonadotropin homologous hormones due to 
inoculation of tilapia pituitary preparations should generate 
steroidogenic responses in-vitro and in-vivo. In this sense, the present 
work would be a contribution to increasing the fry production in some 
cichlid fish, such as tilapia and to improve the induction of maturation in 
several percid fishes (Perciformes). Availability of tilapia fish pituitary 
strongly supports the use of tilapia pituitary preparations, generating an 
alternative treatment as CP and GnRH. 
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